Aligos Therapeutics (NASDAQ:ALGS) on Thursday shared topline results from a mid-stage study for its lead candidate ALG-055009 in patients suffering from a liver condition called metabolic ...

Another player in the space is Viking Therapeutics, which shared phase 2b data from its MASH candidate, also an agonist of the thyroid hormone beta receptor, last November. The asset was tied to a ...

Link to What to Watch: In Theaters and On Streaming Vote in the 1994 Movies Showdown – Round 5 Link to Vote in the 1994 Movies Showdown – Round 5 ...

The Mathematics & Statistics Helpdesk (MASH) was introduced in 2019/20 and supports ALL UG & PG students across the University in their learning of Mathematics & Statistics. This initiative is ...